Yahoo India Web Search

Search results

  1. Dr. Kiran Divi is the Director on Board & Chief Executive Officer at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He officially took on the role of leading Divi’s as the CEO, starting January 2020.

  2. Dr. Kiran Divi is the Director on Board & Chief Executive Officer at Divi’s Laboratories Ltd and has been with Divi’s since August, 2001. He officially took on the role of leading Divi’s as the CEO, starting January 2020.

  3. Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [ 5 ] [ 6 ] [ 2 ] [ 7 ] The company manufactures and custom synthesizes generic APIs, intermediates.

  4. Jul 1, 2024 · Dr Murali K. Divi, aged 73, stands as the wealthiest individual in Hyderabad with a staggering net worth of $7.8 billion (Rs 65k cr ), according to Forbes. The U.S.-trained scientist and entrepreneur is the Founder and Managing Director of Divi’s Laboratories, a multinational pharmaceutical giant.

  5. Oct 17, 2014 · Murali Divi, founder-chairman of the Rs 2,597 crore pharmaceutical contract manufacturing firm Divis Laboratories, insists his main business is running farms and growing orchards

  6. May 1, 2023 · Pushing For Holistic Growth: Murali K. Divi, MD & CEO, Divi's Laboratories. BW Online Bureau May 01, 2023. Divi’s Laboratories has grown to be among the top generic drug makers in the country...

  7. Murali Divi is the founder of Divi’s Labs, one of the top three manufacturers of active pharmaceutical ingredients (API).

  8. Divis Laboratories's Executive Director is N.V. Ramana. Other executives include Kiran S. Divi, Whole-Time Director & Chief Executive Officer; Nilima Prasad Divi, Whole-Time Director (Commercial) and 6 others. See the full leadership team at Craft.

  9. Kiran Satchandra Divi is CEO/Whole Time Director at Divi's Laboratories Ltd. See Kiran Satchandra Divi's compensation, career history, education, & memberships.

  10. New Delhi, Jan 27 () Drug firm Divi's Laboratories on Monday said it has sought shareholers' approval for the re-appointment of Kiran S Divi as the Chief Executive Officer (CEO) of the...